丹诺苏马布与转移性骨病中的佐乐德龙酸:随机对照试验的综合系统性审查和元分析
Benjamin G Wajda1,2, Leah E Ferrie2, Annalise G Abbott1,2,3
1Department of Surgery, Section of Orthopaedic Surgery, University of Calgary, Calgary, AB T2N 1N4, Canada.
Cancers
|February 13, 2025
概括
德诺苏马布 (Dmab) 比索莱德龙酸 (ZA) 更有效地减少骨相关事件并改善骨转移的生命质量. 然而,Dmab在某些患者群体中具有较高的低血症和骨硬化风险.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 卫生经济学 卫生经济学
背景情况:
- 转移性骨病 (MBD) 导致骨相关事件 (SREs),疼痛和降低生活质量.
- 骨质修饰剂 (BMA) 如登苏马布 (Dmab) 和龙酸 (ZA) 用于管理MBD.
- 之前的分析缺乏Dmab和ZA在多个结果和成本效益方面进行全面的比较.
研究的目的:
- 进行全面的分析,比较Denosumab (Dmab) 与zoledronic acid (ZA) 在转移性骨病 (MBD) 的疗效和安全性.
- 评估主要结果,包括生存率,骨折,辐射和SREs的时间.
- 评估二次结果,如不良事件,疼痛,生活质量和成本效益.
主要方法:
- 对相关随机对照试验 (RCT) 进行系统的文献搜索.
- 主要结果的元分析:整体存活率,病理性骨折,骨辐射,SREs的时间.
- 二次结果的元分析:不良事件,疼痛,止痛使用,生活质量,成本.
主要成果:
- 代诺苏马布 (Dmab) 与龙酸 (ZA) 相比,减少了骨辐射需求和延迟了SREs的时间,除了多发性骨髓瘤.
- 在乳腺癌患者中,Dmab使病理骨折发生率降低了39%.
- 这两种药物对整体存活率和疾病进展具有相似的影响.
结论:
- 代诺苏马布 (Dmab) 在减少SRE和改善生活质量和疼痛结果方面显示出优势,阿片类药物的使用量比索莱德龙酸 (ZA) 低.
- 在特定的亚组中,使用Dmab与低血症和骨 necrosis的风险增加有关.
- 成本效益是混合的,取决于癌症类型;Dmab可能是高风险的骨并发症的首选,等待进一步研究癌症特定用途.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
What is the Skeletal System?
52.1K
Overview
52.1K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K


